Engineering

3-D-printed swabs to help fill gap in COVID-19 test kits

Innovation at the University of Louisville involving multiple departments at the university has led to a promising solution for the shortage of swabs in COVID-19 test kits. In response to a request from the Commonwealth of ...

Computer Sciences

Simplified modelling of application and infrastructure

In recent years, the global market has seen a tremendous rise in utility computing, which serves as the back-end for practically any new technology, methodology or advancement in ICT, from healthcare to aerospace. The industry ...

Robotics

A promising step in returning bipedal mobility

Engineers at Caltech have launched a new research initiative aimed at restoring natural and stable locomotion to individuals with walking deficiencies that result from spinal cord injuries and strokes.

Computer Sciences

Could blockchain ensure integrity of clinical trial data?

UC San Francisco researchers have created a proof-of-concept method for ensuring the integrity of clinical trials data with blockchain. The system creates an immutable audit trail that makes it easy to spot any tampering ...

page 1 from 2

Clinical trial

In clinical trials are conducted to allow safety and efficacy data to be collected for new drugs or devices. These trials can only take place once satisfactory information has been gathered on the quality of the product and its non-clinical safety, and Health Authority/Ethics Committee approval is granted in the country where the trial is taking place.

Depending on the type of product and the stage of its development, investigators enroll healthy volunteers and/or patients into small pilot studies initially, followed by larger scale studies in patients that often compare the new product with the currently prescribed treatment. As positive safety and efficacy data are gathered, the number of patients is typically increased. Clinical trials can vary in size from a single center in one country to multicenter trials in multiple countries.

Due to the sizable cost a full series of clinical trials may incur, the burden of paying for all the necessary people and services is usually borne by the sponsor who may be the pharmaceutical or biotechnology company that developed the agent under study. Since the diversity of roles may exceed resources of the sponsor, often a clinical trial is managed by an outsourced partner such as a contract research organization

This text uses material from Wikipedia, licensed under CC BY-SA